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Abstract
Background: Non-specific chronic low back pain (NSCLBP) has become a significant problem due
to high healthcare utilization, rising costs of care and perceived limitations of effectiveness of many
current treatments. Systematic reviews have repeatedly concluded that, on average across
participants, exercise for NSCLBP appears effective in decreasing pain and improving function. Not
all people with NSCLBP benefit from exercise programs and it would assist care-providers and
care-seekers if factors that impact on program effectiveness and success were identified.
Methods and design: The study will be a randomised controlled trial comparing an exercise
rehabilitation program informed by a participant preferences questionnaire compared to a program
without this guideline for patients with chronic low back pain. A sample of 150 patients will be
recruited in Melbourne, Australia through community-based healthcare clinics that provide
supervised exercise rehabilitation programs for people with non-specific chronic low back pain.
Clinicians will be randomly assigned to exercise preferences questionnaire or no questionnaire and
participants will be allocated in a concealed manner. A qualitative focus group study of exercise
instructor feedback about the exercise preferences instrument will be embedded in the research
design. Two qualitative focus group studies will also be conducted for participants in the
intervention and the control groups to obtain feedback about participants' experiences of the two
types of exercise programs. The primary outcomes will be functional ability, pain, fear avoidance,
exercise adherence.
Discussion: This trial will evaluate the effectiveness of individualised exercise prescription
compared to usual exercise prescription for NSCLP and, using feedback following the trial, refine
the exercise preferences questionnaire.
Background
Non-specific chronic low back pain (NSCLBP) has
become a significant problem due to high healthcare uti-
lization, rising costs of care and perceived limitations of
effectiveness of many current treatments. It is a significant
source of long-term disability and absence from work and
a substantial burden in industrialized societies [1-9].
NSCLBP is not a diagnosis but rather a description of back
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and a precise patho-anatomical diagnosis cannot be
given. This accounts for approximately 85% of all low
back pain and does presume that specific pathologies,
such as nerve root compression or tumour, have been
ruled out by appropriate tests and imaging [10]. The con-
dition manifests as a continuation of an initial episode or
periodic recurrences and remissions [11,12].
Systematic reviews have repeatedly concluded that, on
average across participants, exercise for NSCLBP appears
effective in decreasing pain and improving function [13-
20]. Many exercise programs have been designed and
quite different programs appear to have similar effects.
Not all people with NSCLBP benefit from exercise pro-
grams and it would assist care-providers and care-seekers
if factors that impact on program effectiveness and success
were identified [21,22]. Clarification of the ingredients
that make exercise programs enjoyable and inviting
would enable clinicians to prescribe interventions that are
appropriate for the NSCLBP care-seeking population. A
systematic search of the literature demonstrated that there
is no available instrument that measures patient experi-
ence of exercise rehabilitation programs for NSCLBP. It is
currently unknown whether patient expectations are met
or what they experience during exercise programs for
NSCLBP.
Following Monash University Standing Committee on
Ethics in Research Involving Humans (SCERH) approval
(SCERH CF07/1854 – 2007/0558), we conducted qualita-
tive focus group research of participant experience of exer-
cise programs for NSCLBP and factors that they perceived
important for engagement and participation. The results
of this study indicated that people with NSCLBP have a
range of environmental and exercise design preferences
that are important to consider in exercise prescription.
Enablers for exercise participation included shared deci-
sion-making, effective communication, a history of exer-
cise ability and participation, familiarity with exercise
environments and the fitness culture, individualised and
supervised programs, use of preferred environments, fam-
ily support, variety and fun, motivation strategies and
education. Barriers included time constraints, cost, boring
programs, symptom aggravation, consequences of stigma,
dissatisfaction with formal exercise and gym 'culture' [23-
25].
A decision-aid for exercise prescription is currently not
available and the results of our qualitative research have
informed the development of a questionnaire that clini-
cians can use to determine participant exercise preferences
and inform their practice of exercise prescription. This
questionnaire requires testing in the clinical environment
to determine its utility as a method of systematic evalua-
tion of care-seeker needs and preferences related to exer-
cise. The research plan is to implement the questionnaire
in a range of exercise programs that are specific to
NSCLBP, evaluate the effectiveness of individualised exer-
cise prescription and evaluate feedback about the instru-
ment.
Methods/Design
Monash University SCERH has granted approval for this
study (CF08/2015 – 2008000990). The trial will be
reported according to the recommendations of the CON-
SORT Statement [26,27] and the flow of participants
through the study is represented in Figure 1. The quantita-
tive study will compare an exercise rehabilitation program
informed by a participant preferences questionnaire com-
pared to a program without this guideline for patients
with NSCLBP. The qualitative study will evaluate clinician
and participant experience. Patients presenting for exer-
cise prescription will be allocated to clinicians who either




The study will be a randomised controlled trial (RCT)
with an intervention period of six weeks and exercise pro-
grams will be those of usual clinician practice. Outcomes
will be measured at baseline and at 6, 12, 26 and 52 weeks
from baseline.
• Controlling bias
The RCT design includes key method features that have
been recognised as important in minimising bias in clini-
cal trials: true randomisation, concealed allocation, speci-
fication of eligibility criteria, blind outcome assessment,
blind analysis and intention-to-treat analysis.
• Setting
A sample of patients will be recruited in Melbourne, Aus-
tralia through community-based healthcare clinics that
provide supervised exercise rehabilitation programs for
people with NSCLBP.
• Protocol protection
The following mechanisms will be used to ensure that the
trial protocol is applied consistently: protocol manuals
will be developed and all involved researchers will be
trained to ensure that screening, assessment, random allo-
cation and treatment procedures are conducted according
to the protocol; a random sample of treatment sessions
will be audited to check that treatment is administered as
per the protocol.Page 2 of 8
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Participant flow through the RCT (based on CONSORT Statement)Figure 1
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• Clinics and clinicians
The study will be conducted in Melbourne metropolitan
primary health care clinics that provide exercise programs
for rehabilitation of musculoskeletal conditions. The con-
tact details used will be those publicly available in the tel-
ephone directory or online at professional association
websites. The clinics will be approached by telephone or
email/mail advertisement seeking expressions of interest
in research participation.
A phone conversation or meeting will be scheduled with
the practice principal to outline the project and distribute
the Explanatory statement and Clinic Consent Form. After
receipt of signed Clinic Consent, information sessions
will be scheduled to address clinicians and inform them
of the research background and aims. They will be given
an Explanatory Statement to read and keep and a Clini-
cian Consent Form to sign and return to the researcher if
they wish to participate. Reception staff in-service training
will also be conducted to familiarize clinic staff with the
recruitment process, paperwork completion and filing.
• Patients
The opportunity to participate will be offered to every eli-
gible consecutive low back pain patient in order of contact
until adequate numbers of participants are achieved.
Clinic reception staff who are not aware of the research
protocol or aims will approach potential participants who
are patients seeking treatment for low back pain and use a
screening checklist to determine eligibility and interest.
They will record the number of patients invited, the
number who decline, ineligible patients and reasons [see
Additional file 1].
Concealment
• Patients and receptionists
If patients are eligible and interested, reception staff will
give them the Explanatory Statement to read and keep and
a Consent Form that they will sign and return to the recep-
tionist for filing. Following signed consent participants
will complete coded outcome measures and exercise pref-
erence questionnaires and return them sealed to reception
staff for storage in a secure box for retrieval by the
researcher. The completed exercise preferences question-
naire will be put in a sealed envelope, marked EQ, and
forwarded to the treating clinician. The envelope will only
be opened by the clinicians allocated to the questionnaire
group. Reception staff and patients will not know which
practitioners have been allocated to use the completed
exercise preference questionnaire to guide exercise pre-
scription or to the control group.
Randomization
• Clinicians
Clinicians who have consented to participate will be ran-
domly allocated, by computer-generated codes (code:
exercise questionnaire group (EQ); no exercise question-
naire group (NQ)) in sealed opaque envelopes, to one of
two groups with stratification to allow equal representa-
tion of qualifications. These codes will be generated by an
independent researcher who has no contact with trial par-
ticipants. Group 1 clinicians allocated to use the exercise
preferences questionnaire will use the responses to the
exercise preferences questionnaire to inform their exercise
prescription. Group 2 clinicians do not use the exercise
preferences questionnaire and will return the unopened
envelope to a secure storage box in the reception area.
These clinicians will prescribe exercise according to their
usual practice.
The two groups of clinicians will not disclose their group
allocation or any details or findings of the questionnaire.
A code-breaker master document will be kept in a locked
location at the university and cannot be viewed by recep-
tion staff or clinicians.
Eligibility assessment
• Clinicians
Health care practitioners who hold recognized qualifica-
tions in physiotherapy, exercise physiology (masters
degree), chiropractic, osteopathy or certificate 4 training,
who are registered to practice in Victoria and who pre-
scribe exercises are eligible to participate.
• Patients
At the initial consultation clinicians will use a screening
checklist to confirm eligibility. If participants meet the
inclusion criteria the participant and their data will be




The clinicians will be asked to agree not to disclose group
allocation or questionnaire details to patients, colleagues
or researchers.
• Patients
The plain language Explanatory Statement and Patient
Consent Form will inform participants that they have an
equal chance of receiving one of two acceptable exercise
prescription methods.
• Assessor
A blinded examiner will perform all outcome assess-
ments. Participants will be asked to refrain from discuss-
ing their treatment with the outcome assessor. At trialPage 4 of 8
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whether they had been in the experimental or control
group. The data manager and statistician will be unaware
of treatment allocation until completion of analyses.
Sample Size
A total of 120 patients (60 questionnaire group, 60 no
questionnaire group) will be required for 80% power to
detect a 5 point reduction on 100 point measure of func-
tion with 95% confidence using a two-tail test of differ-
ence between group means when raw scores have an
estimated standard deviation of 10/100 points). We will
allow for a 10% loss to follow-up and aim to recruit 75
participants per group. This will enable collection of data
for at least 85% of enrolled participants.
Outcome measures
Socio-demographic data including age, back pain history
and occupation status, will be collected at baseline. The
following outcomes will be assessed at baseline, at com-
pletion of the 6 week intervention and at 12, 26 and 52
weeks: Functional ability: Oswestry Disability Index
(ODI) [28], Pain: Tagged Numeric Pain Scale (NPS) [29],
Fear avoidance: Fear Avoidance Beliefs Questionnaire
(FABQ) [30]. The Exercise Preferences Questionnaire will
be completed at baseline only and the Exercise Diary will
be completed after each exercise session during the inter-
vention and follow-up period. Time to complete the Exer-
cise Preferences Questionnaire will be evaluated by asking
the participant to note the time taken on page two of this
form. Follow-up reminders will be given by phone or SMS
and completed outcome measures returned by pre-paid
envelope or SMS.
Adverse effects or events
No adverse events are anticipated but will be documented
by type, length of time and frequency should they occur.
Data Analysis
Analysis will be by intention to treat. As scores are
expected to improve across time, missing data will be
replaced by the last score carried forward. If mean scores
deteriorate across time, missing data will be replaced by
the last score minus the reduction in scores anticipated
using trend analysis of previous scores. Demographic
characteristics and baseline data will be summarised by
descriptive statistics. Distributions of all continuous data
will be assessed for normality. Between-group compari-
sons of normally distributed data will be performed with
independent t tests. Non-normally distributed data will
be compared with the Mann Whitney U statistic. Relative
risks and their 95% confidence intervals will be used to
report group differences in proportions for similar out-
comes. Continuous variables will be assessed for relation-
ships between baseline scores and outcome. If a
significant relationship is found, analysis of covariance
(ANCOVA) will be conducted to test the effect of the inter-
vention when controlling for the confounding effects of
baseline scores on outcome. Effect sizes with 95% confi-




Two qualitative studies will be embedded within the RCT:
(1) exercise instructor (clinician) feedback about the exer-
cise preferences instrument (2) participant feedback
about their exercise experience. The focus group research
methods will follow the recommendations of Strauss and
Corbin (1998) and Krueger and Casey (2000) [31,32].
Both of these studies will be conducted within one month
of RCT completion. The focus groups will be 2.5 hours
duration and conducted by an experienced facilitator with
a pre-determined set of questions. The sessions will be
audio-taped, minuted and transcribed verbatim for inde-
Table 1: RCT inclusion and exclusion criteria
Inclusion criteria
• over 18 years of age
• non-specific chronic low back pain: pain in the area extending from twelfth rib to buttock fold +/- leg for > 8 weeks
• receiving exercise prescription
• ability to speak, read and write English
Exclusion criteria
• severe cardiovascular or metabolic disease
• inflammatory disease
• spinal tumour or fracture
• nerve root compression/compromise
• spinal cord irritation/cauda equina signs
• osteoporosis.
• PregnancyPage 5 of 8
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pants through the studies is illustrated in Figure 2.
• Controlling bias
Rigour of the qualitative research design will be enhanced
by testing against four constructs: Credibility: independ-
ent data review, coding and theme development by at
least 2 reviewers with several rounds of discussion. Trans-
ferability: a priori recruitment methods that reduce bias
and participant heterogeneity. Dependability: accurate
verbatim transcription of audio tapes and comparisons of
transcript and tape content. Confirmability: consistent
emergent themes from subsequent data.
Study population and recruitment
• Clinicians
Clinicians who have participated in the RCT, who were
allocated to the intervention (exercise preferences ques-
Progress through the stages of selection for focus group studiesFigu  2
Progress through the stages of selection for focus group studies.
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pate in focus group research will be invited to participate.
• Patients
Following completion of the 6 week intervention out-
come assessments, participants in the RCT will be invited
to participate in focus group studies to elicit feedback
about their experiences of the program.
Data collection
Focus groups will be convened at Monash University –
Peninsula campus, or another convenient location. Peo-
ple will only volunteer information if they wish to do so.
An experienced facilitator will use a discussion outline to
guide the conversation and participants will be encour-
aged to talk freely and spontaneously. The focus group
sessions will be audio-taped and a note-taker will record
field notes. Immediately following each focus group the
facilitator and note-taker will meet and complete a debrief
form.
• Data storage and confidentiality
Subjects will be assigned a code number at the first contact
and a pseudonym when tapes are transcribed. This code
number will be the only identifying mark on all subse-
quent data.
• Data analysis
Grounded Theory will be applied in the analysis of the
shared and divergent experiences of clinicians who used
the questionnaire for exercise prescription and patients
who participated in the exercise programs. The method is
based on identification of coded themes in recorded data
and identification of relationships between themes.
Discussion
We have presented the rationale and design of a rand-
omized controlled trial, with embedded qualitative stud-
ies, to investigate and evaluate preferred-exercise
prescription compared to usual exercise prescription on
outcomes for people with non-specific chronic low back
pain. The results of this research will be presented as soon
as they are available.
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